Neocis gets FDA nod for new Yomi component

By staff writers

May 13, 2020 -- Robotic dental implant surgery developer Neocis has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new component for use with its Yomi technology.

Yomi provides robot-assisted guidance relative to preoperative plans based on CT scans and can be used with conebeam CT scanners installed in dental offices. The new component reduces the CT scanner field-of-view requirements for Yomi, which Neocis believes will broaden the market for adoption of its robot-assisted dental surgery system.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking